Ethinylestradiol
| EE | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 296.40 g/mol [1] |
| Appearance | Fine, white to creamy white crystalline powder [1] |
| Odor | Odorless [1] |
| Melting point | 288 to 295 °F (NTP, 1992) [1] |
| Decomposition | When heated to decomposition it emits acrid smoke and irritating fumes. [1] |
| Solubility | less than 1 mg/mL at 70 °F (NTP, 1992) [1] |
| Predicted LogP | 3.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C20H24O2 |
| IUPAC name | (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol |
| SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O |
| InChI | InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1 |
| InChIKey | BFPYWIDHMRZLRN-SLHNCBLASA-N |
| CAS number | 57-63-6 |
| UNII | 423D2T571U |
| PubChem CID | 5991 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 7–36 hours[3] |
| Metabolism | Liver (primarily CYP3A4)[4] |
| Excretion | Feces: 62%, Urine: 38% |
| Routes of administration | By mouth, transdermal, vaginal |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - oral: 2500 mg/kg Rat: - oral: 1200 mg/kg - intraperitoneal: 471 mg/kg [1] |
Ethinylestradiol (also known as ethinyl estradiol, Ethynylestradiol, Ethynyl estradiol, Ethinyloestradiol, Estinyl, 17-Ethinylestradiol, Ginestrene, Lynoral, 17α-Ethynylestradiol or Etinoestryl) is a substance of the phenol and steroid class.
Chemistry
Stereochemistry []
Ethinylestradiol is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Ethinylestradiol matches Lipinski's rule of five.Pharmacology
ATC Classification
- genito urinary system and sex hormones (G)
- sex hormones and modulators of the genital system (G03)
- (G03AA07)
- estrogens (G03C)
- natural and semisynthetic estrogens, plain (G03CA)
- ethinylestradiol (G03CA01)
- antineoplastic and immunomodulating agents (L)
- endocrine therapy (L02)
- hormones and related agents (L02A)
- estrogens (L02AA)
- ethinylestradiol (L02AA03)
MeSH Classification
Mechanism of action []
Ethinylestradiol is a synthetic estrogenic compound. Use of estrogens have a number of effects on the body including reduced bone density. Combined oral contraceptives suppress ovulation by suppressing gonadotrophic hormone, thickening cervical mucus to prevent the travel of sperm, and preventing changes in the endometrium required for implantation of a fertilized egg. Ethinylestradiol decreases luteinizing hormone, decreasing vascularity in the endometrium. It also increases sex hormone binding globulin. [1]
Interactions []
Legal status []
- Other: Ethinylestradiol is a Rx-only.
See also []
External links []
- Ethinylestradiol (Wikipedia)
- Ethinylestradiol (PubChem)
- Ethinylestradiol (Wikidata)
- Ethinylestradiol (DrugBank)
- Ethinylestradiol (ChEMBL)
- Ethinylestradiol (ChEBI)
- Ethinylestradiol (Common Chemistry)
- Ethinylestradiol (HMDB)
- Ethinylestradiol (KEGG)
- Ethinylestradiol (EPA DSSTox)
- Ethinylestradiol (Effect Index)
- Ethinylestradiol (UNII)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5991, Ethinylestradiol. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5991
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ethinylestradiol. UNII: 423D2T571U. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/423D2T571U
Goldzieher JW, Brody SA. Pharmacokinetics of ethinyl estradiol and mestranol. American Journal of Obstetrics and Gynecology. December 1990; 163(6 Pt 2):2114–2119. PMID 2256522. https://doi.org/10.1016/0002-9378(90)90550-Q
Hughes CL, Waters MD. Translational Toxicology: Defining a New Therapeutic Discipline. Humana Press. 23 March 2016. https://books.google.com/books?id=5qPWCwAAQBAJ&pg=PA73
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:31:56 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:31:52 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:31:52 |
| gsrs | ok | 2026-11-20 07:31:53 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0001926) | 2026-11-20 07:31:52 |
| kegg | ok | 2026-11-20 07:31:56 |
| pubchem | ok | 2026-11-20 07:31:52 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:31:52 | |
| sider | missing (not in SIDER) | 2026-11-20 07:31:52 |
| structure | ok | 2026-11-20 07:31:52 |
| wikipedia | ok | 2026-11-20 07:31:53 |